Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis
Principal Investigator (?)
Study Number
F18135
Summary
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of adolescent and adult participants with moderate to severe Atopic dermatitis (AD) who are candidates for systemic therapy. 
Phase (?)
Phase III
Sponsor (?)
Contact

Debra Rodgers

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0